Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey

References

• Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG, Takata GS. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304:2161. doi:10.1001/jama.2010.1651.
   PubMed Web of Science ®Google Scholar
• Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875. doi:10.1001/jama.279.11.875.
   PubMed Web of Science ®Google Scholar
• Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, et al. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15- CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine. 2011;29:8870–76. doi:10.1016/j.vaccine.2011.09.078.
   PubMed Web of Science ®Google Scholar
• Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. 2000;19(5 Suppl):S37. doi:10.1097/00006454-200005001-00007.
   PubMed Web of Science ®Google Scholar
• Ceyhan M. Konjuge Pnömokok Aşılarında Son Gelişmeler: 13-Valanlı Konjuge Pnömokok Aşısı. J Pediatr Inf. 2011;5:68–73. doi:10.5152/ced.2011.25.
   Google Scholar
• World Health Organization (WHO). Immunization summary. http://apps.who.int/gho/data/node.main.PCV3n?lang=en
   Google Scholar
• Vojtek I, Nordgren M, Hoet B. Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challenges. Int J Pediatr Otorhinolaryngol. 2017;100:174–82. doi:10.1016/j.ijporl.2017.07.009.
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187–95.
   PubMed Web of Science ®Google Scholar
• Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403–09. doi:10.1056/NEJM200102083440602.
   PubMed Web of Science ®Google Scholar
• Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics. 2008;121:253–60. doi:10.1542/peds.2007-0619.
   PubMed Web of Science ®Google Scholar
• Gisselsson-Solen M. Trends in otitis media incidence after conjugate pneumococcal vaccination: a national observational study. Pediatr Infect Dis J. 2017;36:1027–31. doi:10.1097/INF.0000000000001654.
   PubMed Web of Science ®Google Scholar
• Fortunato F, Marinelli D, Cappelli MG, Cozza V, Prato R. Impact of pneumococcal conjugate universal vaccination on pneumococcal disease in Italian children. J Immunol Res. 2015;2015:206757. doi:10.1155/2015/206757. Epub 2015 Aug 16.
   Web of Science ®Google Scholar
• Lau WC, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, Sharland M, Wong IC, Hsia Y. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine. 2015;33:5072–79. doi:10.1016/j.vaccine.2015.08.022.
   PubMed Web of Science ®Google Scholar
• Suarez V, Michel F, Toscano CM, Bierrenbach AL, Gonzales M, Alencar AP, Ruiz Matus C, Andrus JK, de Oliveira LH. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses. Vaccine. 2016;34:4738–43. doi:10.1016/j.vaccine.2016.07.027.
   PubMed Web of Science ®Google Scholar
• Wals PD, Carbon M, Sévin E, Deceuninck G, Ouakki M. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J. 2009;28:e271–5. doi:10.1097/INF.0b013e3181bad212.
   PubMedGoogle Scholar
• Pichichero M, Kaur R, Scott DA, Gruber WC, Trammel J, Almudevar A, Center KJ. Effectiveness of 13- valent pneumococcal conjugate vaccination for protection against acute otitis media caused by streptococcus pneumoniae in healthy young children: a prospective observational study. Lancet Child Adolesc Health. 2018;2:561–68. doi:10.1016/S2352-4642(18)30168-8.
   PubMedGoogle Scholar
• al; SL K, KJ C, WJ B, Ling-Lin P, JR R, JS B, TQ T, JA H, TR P, Gurtman A, et al. Multicenter surveillance of streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015;60:1339–45. doi:10.1093/cid/civ067.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media. Clin Infect Dis. 2016;63:611–18. doi:10.1093/cid/ciw347.
   PubMed Web of Science ®Google Scholar
• Syrjänen RK, Herva EE, Mäkelä PH, Puhakka HJ, Auranen KJ, Takala AK, Kilpi TM. The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age. Pediatr Infect Dis J. 2006;25:1032–36. doi:10.1097/01.inf.0000241097.37428.1d.
   PubMed Web of Science ®Google Scholar
• Soysal A, Karabağ-Yılmaz E, Kepenekli E, Karaaslan A, Cagan E, Atıcı S, Atınkanat-Gelmez G, Boran P, Merdan S, Hasdemir U. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of streptococcus pneumoniae among healthy children in Turkey. Vaccine. 2016;34:3894–900. doi:10.1016/j.vaccine.2016.05.043.
   PubMed Web of Science ®Google Scholar
• Andrade AL, Ternes YM, Vieira MA, Moreira WG, Lamaro-Cardoso J, Kipnis A, Cardoso MR, Brandileone MC, Moura I, Pimenta FC. Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil. PLoS One. 2014;9:e98128. doi:10.1371/journal.pone.0098128.
   PubMed Web of Science ®Google Scholar
• Sartori AL, Minamisava R, Bierrenbach AL, Toscano CM, Afonso ET, Morais-Neto OL, Antunes JLF, Cristo EB, Andrade AL. Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil. PLoS One. 2017;12:e0179222. doi:10.1371/journal.pone.0179222.
   PubMed Web of Science ®Google Scholar
• Palmu AA, Verho J, Jokinen J, Karma P, Kilpi TM. The seven - valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J. 2004;23:732–38. doi:10.1097/01.inf.0000133049.30299.5d.
   PubMed Web of Science ®Google Scholar
• Le TM, Rovers MM, Veenhoven RH, Sanders EA, Schilder AG. Effect of pneumococcal vaccination on otitis media with effusion in children older than 1 year. Eur J Pediatr. 2007;166:1049–52. doi:10.1007/s00431-006-0379-6.
   PubMed Web of Science ®Google Scholar
• van Heerbeek N, Straetemans M, Wiertsema SP, Ingels KJ, Rijkers GT, Schilder AG, Sanders EA, Zielhuis GA. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion. Pediatrics. 2006;117:603–08. doi:10.1542/peds.2005-0940.
   PubMed Web of Science ®Google Scholar
• Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J, IJzerman E, Hermans P, de Groot R, Zegers B, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet. 2003;361:2189–95. doi:10.1016/S0140-6736(03)13772-5.
   PubMed Web of Science ®Google Scholar
• Fortanier AC, Venekamp RP, Hoes AW, Schilder AGM. Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study. Vaccine. 2019;37(11):1528–32. doi:10.1016/j.vaccine.2019.01.064.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Kunimoto M, Takeno S, Sumiya T, Ishino T, Sugino H, Hirakawa K. Influence of pneumococcal conjugate vaccines on acute otitis media in Japan. Auris Nasus Larynx. 2018;45:718–21. doi:10.1016/j.anl.2017.10.006.
   PubMed Web of Science ®Google Scholar